Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

Otologic Pharmaceutics, Inc. is a company committed to developing treatments for acute hearing loss to reduce the development of permanent hearing disorders.

Year Founded: 2008

Year Partnered: 2014

Category: BioTech/Pharma

Fund: Angel Fund I, Accelerate, Oklahoma Seed Capital Fund

Press Release: Otologics Link

www. otologicpharma.com

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

618 E. Third Street, Suite 1
Tulsa, OK 74120
PHONE 918/582-5592
Click HERE for printable map with directions.
Copyright 2021 i2E, Inc. | All Rights Reserved
  • #withOklahomaStartups
  • #withOklahomaStartups
  • #withOklahomaStartups- copy
  • 2016 BrewFest
  • 2018 Paulsen Award Application
  • 2019 Business Plan Submittal Form
  • 2019 Intent to Compete
  • 2019 Oral Competition Submittal Form
  • 2019 Paulsen Award Application
  • 2020 Business Plan Submittal Form
  • 2020 Oral Competition Submittal Form
  • 2020 Paulsen Award Application
  • 2021 Official Application Form
  • 2021 Oral Competition Submittal Form
  • 2021 Paulsen Award Application
  • 4DSales
  • About
  • About i2E
  • About Us
  • ACT Tulsa
  • Add Listing
  • Alkami
  • Biolytx
  • BP Endo
  • Clear River Enviro
  • Concept Fund
  • Contact
  • COVID-19 News from i2E
  • COVID19 Resources for Scalable Startups
  • CreditPoint
  • Datebox
  • DermaMedics
  • DEX Pump
  • DigitalSix
  • Directory
  • Directory Dashboard
  • Docvia
  • Driven Analytics
  • e3
  • e3 Goes Virtual
  • e3: #withOklahomaStartups
  • Entrepreneurial Development
  • Entrepreneurial Summit
  • Entrepreneurial Summit Speakers
  • Entrepreneurs-in-Residence
  • Entrepreneurship
  • Events
  • Events
  • Exaptive
  • Exerbotics
  • Expert TA
  • Founder’s Book Nook
  • Home
  • Home
  • i2E Directory
  • i2E Events
  • iMCI
  • iMCI Investment Funds
  • Investments
  • iRecommend
  • Kirrhos
  • Letter from iMCI’s Executive in Residence in a time of great uncertainty
  • Library
  • Lifetone
  • Linear Health Sciences
  • Love’s Cup
    • Forms
    • High Growth
    • Paulsen Awards
    • Small Business
    • Timeline
  • Love’s Cup is Unstoppable
  • Love’s Cup W-9
  • MaxQ
  • Moleculera Labs
  • Monscierge
  • MS Pen Technologies
  • My Account
  • News
  • Newsletter
  • Newsletter Archive
  • OKBio
  • OKBio Directory
  • OMRF Glioblastoma
  • Otologics Pharmaceuticals
  • Past Winners
  • PhotoniCare
  • PolySkope Labs
  • Portfolio
  • Portfolio 3
  • Private Partners Opportunity Fund
  • Progentec Diagnostics
  • Q&A with Kevin Moore
  • Q&A with Michael Basch
  • Quarterly Report
  • Raw Space for Rent
  • Resources
  • Roll to Roll Technologies
  • Selexys Pharmaceuticals
  • Send a Ride
  • Simergent
  • Spiers New Technologies
  • Synercon Technologies
  • Tailwind
  • Ten Nine Technologies
  • Testimonials
  • Tetherex Pharmaceuticals
  • The Greg Main Distinguished Scholar Award
  • THG Energy Solutions
  • Thoughts from local business leaders and startup founders on the effects of COVID on their industry
  • Thoughts Post Shut In
  • Tulsa Collab: COVID-19 Efforts & Resources for Entrepreneurs
  • Tulsa GEW
  • Valve Systems International
  • Venture Advisory Services
  • Video
  • Virtuoso
  • Webmail Test Page
  • WeGoLook
  • Well Checked Systems
  • Whiteboard CRM
i2E